Enoch Mwanje v Neogenesis Fertility Centre Limited and Others (Company Petition 89044 of 2025)
Observed later treatment
No later-treatment classification is recorded for this judgment.
Citator coverage is limited to judgments in the Wakilii corpus and source-matched treatment records. Absence of a signal is not an assertion that the case remains good law.
AI-generated summary. This summary was generated by AI from the full text of the judgment. It may contain errors or omissions—always read the source judgment before relying on it.
Holding
The Registrar of Companies held that the affairs of Neogenesis Fertility Centre Limited were conducted in a manner oppressive to the petitioner, a minority shareholder, contrary to Section 243 of the Companies Act. The petitioner was excluded from company meetings, denied notice of meetings, and denied access to financial records. The arbitration clause in the company's Articles of Association was found inapplicable as the dispute arose from oppressive conduct, not a voluntary share transfer. The Registrar ordered a buyout of the petitioner's shares at fair value determined by an independent valuer.
Outcome
Petition granted. Petitioner's shares to be bought out at fair value determined by independent valuer. Company to appoint valuer within 31 days and complete buyout within 180 days of valuation.
Facts
Enoch Mwanje, a founding shareholder and non-executive director of Neogenesis Fertility Centre Limited, held 16 shares in the company incorporated on 14 February 2017. The company had five founding shareholders, each holding 16 shares. Mwanje alleged he was excluded from company meetings, that no board or annual general meetings had been held since incorporation, that the company failed to prepare and file audited financial statements, and that the other shareholders acquired the shares of Dr. Denis Kinene without his participation or notice. Mwanje commissioned a forensic audit which revealed material discrepancies in financial statements and lack of cooperation from management. The respondents denied the allegations, asserting that Mwanje, as Chairman of the Board, was responsible for convening meetings but failed to do so, and that he had been provided access to company records. The respondents offered to purchase Mwanje's shares but the parties could not agree on valuation.
Issues
- Whether the arbitration clause in the Company's Articles of Association is binding in the context of this dispute?
- Whether there was oppression occasioned to the Petitioner pursuant to section 243 of the Companies Act, Cap 106?
- What remedies are available to the parties?
Orders
- The affairs of Neogenesis Fertility Centre Ltd were conducted in a manner oppressive to the Petitioner contrary to Section 243 of the Companies Act, Cap. 106.
- The Petitioner's shares in the First Respondent Company shall be bought out at a fair value, either by the Respondent Company, or in the alternative by the 2nd, 3rd and 4th Respondents jointly or severally.
- A qualified and independent valuer shall be appointed within thirty one (31) days from the date of this ruling by mutual agreement of the parties, and in default of agreement by a competent Court, for purposes of determining the fair value of the Petitioner's shareholding and contributions in the Company.
- The valuation shall be conducted in accordance with internationally accepted valuation principles and standards, taking into account the Petitioner's shareholding, his capital contributions, historical participation, and any other relevant equitable considerations necessary to arrive at a fair and just valuation.
- The valuation report shall be completed and submitted to the parties within ninety (90) days from the date of appointment of the independent valuer.
- Upon receipt of the valuation report, the purchase price shall be paid to the Petitioner within one hundred eighty (180) days, unless otherwise agreed by the parties in writing.
- Upon full payment of the purchase price, the Petitioner shall execute all necessary transfer instruments and documents to effect the transfer of his shares, and the Company shall update all statutory records accordingly.
- Pending completion of the buy-out process, all parties shall maintain the status quo and shall refrain from any acts likely to prejudice the Company's operations, assets, financing arrangements, employees, contractual obligations, or commercial reputation.
- The costs of the valuation shall be borne by the Company.
- Each party shall bear its own costs.
Rules and key headnotes
Legislation cited (12)
- Companies Act Cap 106 s.243
- Companies Act Cap 106 s.134
- Companies Act Cap 106 s.150
- Companies Act Cap 106 s.151
- Companies Act Cap 106 s.152
- Companies Act Cap 106 s.136
- Companies Act Cap 106 s.148
- Companies Act Cap 106 s.244
- Companies Act Cap 106 s.286
- Companies Act Cap 106 s.14(2)
- Companies Act Cap 106 s.174(5)
- Companies (Powers of the Registrar) Regulations SI No. 71 of 2016 Reg.32
Cases cited (5)
- Matthew Rukikaire Mathew v Incafex (U) Ltd (Civil Appeal No. 03 of 2015)
- Re Nakivubo Chemists (U) Ltd [1977] HCB 311
- Elder vs Elder & Watson Ltd. [1952] SC 49
- Edward Ssenteza and another v Donnie Company Limited and another (HCT-00-CV-CI-0005-2016)
- Foss v Harbottle (1843) 2 Hare 461, 67 ER 189
Full judgment
The original judgment as reported. Read the original PDF before relying on any passage.